Case scenario: Self-extraction of intrathecal pump medication with a concomitant intrathecal granulomatous mass

Anesthesiology

Volumn 114, Issue 2, 2011, Pages 424-430

  Williams, Bryan S ^a   Wong, David ^b   Amin, Sandeep ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; CLONIDINE; FENTANYL; HYDROCODONE; MORPHINE; PARACETAMOL;

ADULT; ARTICLE; CANNULATION; CASE REPORT; CEREBROSPINAL FLUID; CHRONIC PAIN; DRUG DELIVERY SYSTEM; DRUG DEPENDENCE TREATMENT; DRUG DOSE ESCALATION; DRUG WITHDRAWAL; FEMALE; GRANULOMATOSIS; HEMANGIOMA; HUMAN; MORPHINE ADDICTION; MYELOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS VERTEBROPLASTY; PRIORITY JOURNAL; SPINAL PAIN; VENOUS REFLUX;

EID: 79251648591     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181f7dafa     Document Type: Article

References (33)

1. Onofrio BM, Yaksh TL, Arnold PG: Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc 1981; 56:516-20
2. Wang JK, Nauss LA, Thomas JE: Pain relief by intrathecally applied morphine in man. ANESTHESIOLOGY 1979; 50:149-51
3. Kumar K, Kelly M, Pirlot T: Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: Longterm benefits and efficacy. Surg Neurol 2001; 55:79-86
4. Kongkam P, Wagner DL, Sherman S, Fogel EL, Whittaker SC, Watkins JL, McHenry L, Lehman GA: Intrathecal narcotic infusion pumps for intractable pain of chronic pancreatitis: A pilot series. Am J Gastroenterol 2009; 104:1249-55
5. Kumar K, Bodani V, Bishop S, Tracey S: Use of intrathecal bupivacaine in refractory chronic nonmalignant pain. Pain Med 2009; 10:819-28
6. Angel IF, Gould HJ Jr., Carey ME: Intrathecal morphine pump as a treatment option in chronic pain of nonmalignant origin. Surg Neurol 1998; 49:92-8
7. Anderson VC, Burchiel KJ: A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery 1999; 44:289-300
8. Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, Buchser E, Català E, Bryce DA, Coyne PJ, Pool GE, Implantable Drug Delivery Systems Study Group: Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: Impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002; 20:4040-9
9. Aprili D, Bandschapp O, Rochlitz C, Urwyler A, Ruppen W: Serious complications associated with external intrathecal catheters used in cancer pain patients: A systematic review and meta-analysis. ANESTHESIOLOGY 2009; 111:1346-55
10. Coffey RJ, Owens ML, Broste SK, Dubois MY, Ferrante FM, Schultz DM, Stearns LJ, Turner MS: Mortality associated with implantation and management of intrathecal opioid drug infusion systems to treat noncancer pain. ANESTHESIOLOGY 2009; 111:881-91
11. Deer TR, Raso LJ, Garten TG: Inflammatory mass of an intrathecal catheter in patients receiving baclofen as a sole agent: A report of two cases and a review of the identification and treatment of the complication. Pain Med 2007; 8:259-62
12. Kumar V, Abbas AK, Fausto N, Aster J: Acute and chronic inflammation, Robbins and Cotran Pathologic Basis of Disease, 8th Ed. Saunders Elsevier, Philadelphia, 2010; pp 73- 4
13. Yaksh TL, Horais KA, Tozier NA, Allen JW, Rathbun M, Rossi SS, Sommer C, Meschter C, Richter PJ, Hildebrand KR: Chronically infused intrathecal morphine in dogs. ANESTHESIOLOGY 2003; 99:174-87
14. Allen JW, Horais KA, Tozier NA, Wegner K, Corbeil JA, Mattrey RF, Rossi SS, Yaksh TL: Time course and role of morphine dose and concentration in intrathecal granuloma formation in dogs: A combined magnetic resonance imaging and histopathology investigation. ANESTHESIOLOGY 2006; 105: 581-9
15. North RB, Cutchis PN, Epstein JA, Long DM: Spinal cord compression complicating subarachnoid infusion of morphine: Case report and laboratory experience. Neurosurgery 1991; 29:778-84
16. Miele VJ, Price KO, Bloomfield S, Hogg J, Bailes JE: A review of intrathecal morphine therapy related granulomas. Eur J Pain 2006; 10:251-61
17. Deer TR: A prospective analysis of intrathecal granuloma in chronic pain patients: A review of the literature and report of a surveillance study. Pain Physician 2004; 7:225-8
18. Yaksh TL, Hassenbusch S, Burchiel K, Hildebrand KR, Page LM, Coffey RJ: Inflammatory masses associated with intrathecal drug infusion: A review of preclinical evidence and human data. Pain Med 2002; 3:300-12
19. Follett KA: Intrathecal analgesia and catheter-tip inflammatory masses. ANESTHESIOLOGY 2003; 99:5-6
20. Kittelberger KP, Buchheit TE, Rice SF: Self-extraction of intrathecal pump opioid (letter). ANESTHESIOLOGY 2004; 101: 807
21. Burton AW, Conroy B, Garcia E, Solanki D, Williams CG: Illicit substance abuse via an implanted intrathecal pump. ANESTHESIOLOGY 1998; 89:1264-7
22. Hassenbusch S, Burchiel K, Coffey RJ, Cousins MJ, Deer T, Hahn MB, Pen SD, Follett KA, Krames E, Rogers JN, Sagher O, Staats PS, Wallace M, Willis KD: Management of intrathecal catheter-tip inflammatory masses: A consensus statement. Pain Med 2002; 3:313-23
23. Phillips J, Escott E, Moossy J, Kellermier H: Imaging appearance of intrathecal catheter tip granulomas: Report of three cases and review of the literature. AJR 2007; 189:W375-81
24. Blount JP, Remley KB, Yue SK, Erickson DL: Intrathecal granuloma complicating chronic spinal infusion of morphine. Report of three cases. J Neurosurg 1996; 84:272-6
25. Deer TR, Raso LJ, Coffey RJ, Allen JW: Intrathecal baclofen and catheter tip inflammatory mass lesions (granulomas): A reevaluation of case reports and imaging findings in light of experimental, clinicopathological, and radiological evidence. Pain Med 2008; 9:391-5
26. Deer T, Krames ES, Hassenbusch SJ, Burton A, Caraway D, Dupen S, Eisenach J, Erdek M, Grigsby E, Kim P, Levy R, McDowell G, Mekhail N, Panchal S, Prager J, Rauck R, Saulino M, Sitzman T, Staats P, Stanton-Hicks M, Stearns L, Willis KD, Witt W, Follett K, Huntoon M, Liem L, Rathmell J, Wallace M, Buchser E, Cousins M, Ver Donck A: Polyanalgesic Consensus Conference 2007: Recommendations for the management of pain by intrathecal (intraspinal) drug delivery: Report of an Interdisciplinary Expert Panel. Neuromodulation 2007; 10:300-8
27. Coffey RJ, Burchiel K: Inflammatory mass lesions associated with intrathecal drug infusion catheters: Report and observations on 41 patients. Neurosurgery 2002; 50:78-86
28. Waara-Wolleat KL, Hildebrand KR, Stewart GR: A review of intrathecal fentanyl and sufentanil for the treatment of chronic pain. Pain Med 2006; 7:251-9
29. Dario A, Scamoni C, Picano M, Fortini G, Cuffari S, Tomei G: The infection risk of intrathecal drug infusion pumps after multiple refill procedures. Neuromodulation 2005; 8:36-9
30. Gradert TL, Baze WB, Satterfield WC, Hildebrand KR, Johansen MJ, Hassenbusch SJ: Safety of chronic intrathecal morphine infusion in a sheep model. ANESTHESIOLOGY 2003; 99: 188-98
31. Toombs JD, Follett KA, Rosenquist RW, Benton LM: Intrathecal catheter tip inflammatory mass: A failure of clonidine to protect. ANESTHESIOLOGY 2005; 102:687-90
32. Johansen MJ, Satterfield WC, Baze WB, Hildebrand KR, Gradert TL, Hassenbusch SJ: Continuous intrathecal infusion of hydromorphone: Safety in the sheep model and clinical implications. Pain Med 2004; 5:14-25
33. Anderson VC, Cooke B, Burchiel KJ: Intrathecal hydromorphone for chronic nonmalignant pain: A retrospective study. Pain Med 2001; 2:287-97